<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02144129</url>
  </required_header>
  <id_info>
    <org_study_id>EMS_COL</org_study_id>
    <secondary_id>Substudy 1</secondary_id>
    <nct_id>NCT02144129</nct_id>
  </id_info>
  <brief_title>Effects of WB-EMS in Ulcerative Colitis Patients</brief_title>
  <official_title>Effects of Different Types of Whole Body Electromyostimulation (WB-EMS) Application on Body Composition, Muscle Strength and Quality of Life in Patients With Ulcerative Colitis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Erlangen-Nürnberg Medical School</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Erlangen-Nürnberg</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Erlangen-Nürnberg Medical School</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the effect of 12 weeks of WB-EMS either applicated
      passive in a supine resting position or active during slight movements compared with a
      non-training control group on body composition, muscle strength and QoL in patients with
      ulcerative colitis.

      Our main hypothesis is that active WB-EMS application is significantly more favorable to
      address our primary endpoints compared with passive application.

      Our secondary hypothesis is that passive WB-EMS application is significantly more favorable
      to address our primary endpoints compared with non-training control.
    </textblock>
  </brief_summary>
  <overall_status>Withdrawn</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">January 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Lean Body Mass</measure>
    <time_frame>12 weeks, baseline to 12 week follow-up</time_frame>
    <description>Lean Body Mass (LBM) and Appendicular Skeletal Muscle Mass (ASMM) as assessed by Dual-Energy-x-Ray Absorptiometry (DXA)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Isokinetic muscle strength</measure>
    <time_frame>12 weeks, baseline to 12 week follow-up</time_frame>
    <description>Isokinetic muscle strength of the leg extensors and - flexors as assessed by a isokinetic leg strength</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of Life (QoL)</measure>
    <time_frame>12 weeks, baseline to 12 week follow-up</time_frame>
    <description>QoL as assessed by inflammatory bowel disease questionnaire (IBDQ-D) and Depression Scores</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Isometric muscle strength</measure>
    <time_frame>12 weeks, baseline 12 week follow-up</time_frame>
    <description>Isometric strength of the trunk flexors.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Aerobic capacity</measure>
    <time_frame>12 weeks, baseline to 12 weel follow-up</time_frame>
    <description>Aerobic capacity as assessed by 6 min walking test</description>
  </other_outcome>
  <other_outcome>
    <measure>Inflammatory Markers</measure>
    <time_frame>12 weeks, baseline to 12 week follow-up</time_frame>
  </other_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">0</enrollment>
  <condition>Ulcerative Colitis</condition>
  <arm_group>
    <arm_group_label>active WB-EMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 sessions/week with 20 min of active WB-EMS application</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Passive WB-EMS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 sessions/week with 20 min of passive WB-EMS application in a resting supine position</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Inactive Control Group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>sedentary non-training control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>active Whole Body Electromyostimulation</intervention_name>
    <arm_group_label>active WB-EMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Passive WB-EMS</intervention_name>
    <arm_group_label>Passive WB-EMS</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>WB-EMS application</intervention_name>
    <arm_group_label>active WB-EMS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ulcerative colitis

          -  ambulatory subjects

        Exclusion Criteria:

          -  variables that conflicts with WB-EMS application (e.g. cardiac pacemakers)

          -  absence of more than two weeks during the interventional period.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yurdagül Zopf, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Wolfgang K Kemmler, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Erlangen-Nürnberg Medical School</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Weineck, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Erlangen-Nürnberg</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Medizinische Klinik 1, University of Erlangen-Nurnberg</name>
      <address>
        <city>Erlangen</city>
        <state>Franconia</state>
        <zip>91054</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Kemmler W, von Stengel S. Whole-body electromyostimulation as a means to impact muscle mass and abdominal body fat in lean, sedentary, older female adults: subanalysis of the TEST-III trial. Clin Interv Aging. 2013;8:1353-64. doi: 10.2147/CIA.S52337. Epub 2013 Oct 7.</citation>
    <PMID>24130433</PMID>
  </reference>
  <reference>
    <citation>Kemmler W, Bebenek M, Engelke K, von Stengel S. Impact of whole-body electromyostimulation on body composition in elderly women at risk for sarcopenia: the Training and ElectroStimulation Trial (TEST-III). Age (Dordr). 2014 Feb;36(1):395-406. doi: 10.1007/s11357-013-9575-2. Epub 2013 Aug 16.</citation>
    <PMID>23949160</PMID>
  </reference>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2014</study_first_submitted>
  <study_first_submitted_qc>May 20, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2014</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Erlangen-Nürnberg Medical School</investigator_affiliation>
    <investigator_full_name>Wolfgang Kemmler</investigator_full_name>
    <investigator_title>Professor Dr.</investigator_title>
  </responsible_party>
  <keyword>Whole Body Electromyostimulation</keyword>
  <keyword>Inflammatory Bowel Disease</keyword>
  <keyword>Lean Body Mass</keyword>
  <keyword>Muscle Strength</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colitis</mesh_term>
    <mesh_term>Ulcer</mesh_term>
    <mesh_term>Colitis, Ulcerative</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

